sec filing
AR
NASDAQ · ARTL
Artelo Biosciences, Inc.
Healthcare · Biotechnology
$3.75
Up+$0.22 (+5.87%)
Updated Sep 17, 2026, 11:19 PM
SID Score
5.0/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 2.75M
- P/E ratio
- -0.1
- Dividend yield
- 0.00%
- 52-week range
- $0.66 – $19.91
- Volume
- 277.96K
- Avg. volume
- 491.32K
Price performance
ARTL price history
1M range · 20 trading sessions · Daily adjusted prices
ARTL closed at $3.75 after 20 trading sessions, up 420.83% for the selected period.
- Last close
- $3.75
- Period change
- +420.83%
- Period low
- $0.69
- Period high
- $6.52
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 16, 2026 | $4.90 | $4.90 | $3.45 | $3.75 | 277.96K |
| Sep 15, 2026 | $4.88 | $5.6499 | $4.88 | $5.34 | 91.46K |
| Sep 14, 2026 | $5.28 | $5.49 | $4.86 | $4.87 | 54.92K |
| Sep 11, 2026 | $5.69 | $5.84 | $5.35 | $5.43 | 41.93K |
| Sep 10, 2026 | $5.89 | $6.00 | $5.6101 | $5.63 | 43.51K |
| Sep 9, 2026 | $6.4147 | $6.4147 | $5.98 | $5.98 | 29.28K |
| Sep 8, 2026 | $6.135 | $6.38 | $5.918 | $6.19 | 10.86K |
| Sep 4, 2026 | $6.25 | $6.345 | $5.92 | $6.04 | 27.76K |
| Sep 3, 2026 | $6.60 | $6.805 | $6.22 | $6.22 | 27.79K |
| Sep 2, 2026 | $6.10 | $6.7057 | $5.9911 | $6.52 | 43.16K |
| Sep 1, 2026 | $6.05 | $6.3899 | $5.70 | $6.155 | 85.71K |
| Aug 31, 2026 | $5.95 | $6.7899 | $5.34 | $6.36 | 591.49K |
| Aug 28, 2026 | $5.9301 | $6.1182 | $5.5656 | $5.9643 | 266.71K |
| Aug 27, 2026 | $6.1038 | $6.282 | $4.68 | $5.949 | 93.17K |
| Aug 26, 2026 | $6.3454 | $6.57 | $6.3454 | $6.3954 | 10.28K |
| Aug 25, 2026 | $6.30 | $6.462 | $6.12 | $6.4548 | 15.91K |
| Aug 24, 2026 | $0.6789 | $0.7098 | $0.66 | $0.689 | 105.87K |
| Aug 21, 2026 | $0.72 | $0.73 | $0.6803 | $0.692 | 108.9K |
| Aug 20, 2026 | $0.7155 | $0.75 | $0.7001 | $0.7124 | 350.68K |
| Aug 19, 2026 | $0.7155 | $0.7499 | $0.7072 | $0.72 | 200.52K |
Latest ARTL news
The latest Smart Investors Daily articles mentioning ARTL.
Stock researchCompany · Financials
Loading stock research…